title: Coumarin-suberoylanilide hydroxamic acid as a fluorescent probe for determining binding affinities and off-rates of histone deacetylase inhibitors.
abstract: Histone deacetylases (HDACs) are intimately involved in epigenetic regulation and, thus, are one of the key therapeutic targets for cancer, and two HDAC inhibitors, namely suberoylanilide hydroxamic acid (SAHA) and romidepsin, have been recently approved for cancer treatment. Because the screening and detailed characterization of HDAC inhibitors has been time-consuming, we synthesized coumarin-SAHA (c-SAHA) as a fluorescent probe for determining the binding affinities (K(d)) and the dissociation off-rates (k(off)) of the enzyme-inhibitor complexes. The determination of the above parameters relies on the changes in the fluorescence emission intensity (λ(ex)=325 nm, λ(em)=400 nm) of c-SAHA due to its competitive binding against other HDAC inhibitors, and such determination neither requires employment of polarization accessories nor is dependent on the fluorescence energy transfer from the enzyme's tryptophan residues to the probe. Our highly sensitive and robust analytical protocol presented here is applicable to most of the HDAC isozymes, and it can be easily adopted in a high-throughput mode for screening the HDAC inhibitors as well as for quantitatively determining their K(d) and k(off) values.
authors.affiliation: Department of Chemistry and Biochemistry, North Dakota State University, Fargo, ND 58105, USA.
authors.forename: Raushan K
authors.initials: RK
authors.lastname: Singh
authors.forename: Tanmay
authors.initials: T
authors.lastname: Mandal
authors.forename: Narayanaganesh
authors.initials: N
authors.lastname: Balasubramanian
authors.forename: Gregory
authors.initials: G
authors.lastname: Cook
authors.forename: D K
authors.initials: DK
authors.lastname: Srivastava
mesh_terms: D003374:Coumarins / Q000737:chemistry*; D047630:Depsipeptides / Q000737:chemistry / Q000494:pharmacology; D005456:Fluorescent Dyes / Q000737:chemistry*; D056572:Histone Deacetylase Inhibitors / Q000737:chemistry* / Q000494:pharmacology; D006655:Histone Deacetylases / Q000235:genetics / Q000378:metabolism; D006801:Humans; D006877:Hydroxamic Acids / Q000138:chemical synthesis / Q000737:chemistry* / Q000494:pharmacology; D007700:Kinetics; D011485:Protein Binding; D011994:Recombinant Proteins / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism; D012097:Repressor Proteins / Q000037:antagonists & inhibitors* / Q000235:genetics / Q000378:metabolism; D013050:Spectrometry, Fluorescence; D000077337:Vorinostat
chemical_list: D003374:Coumarins; D047630:Depsipeptides; D005456:Fluorescent Dyes; D056572:Histone Deacetylase Inhibitors; D006877:Hydroxamic Acids; D011994:Recombinant Proteins; D012097:Repressor Proteins; D000077337:Vorinostat; C030123:coumarin; C087123:romidepsin; C409470:HDAC8 protein, human; D006655:Histone Deacetylases
references.citation: J Med Chem. 2005 Jul 28;48(15):5047-51
references.pmid: 16033284
references.citation: Biochemistry. 1998 Mar 10;37(10):3499-508
references.pmid: 9521671
references.citation: Anal Biochem. 2007 Mar 1;362(1):136-41
references.pmid: 17250798
references.citation: Nat Biotechnol. 2007 Jan;25(1):84-90
references.pmid: 17211407
references.citation: Anal Biochem. 2008 Jan 1;372(1):82-8
references.pmid: 17920554
references.citation: Nature. 2000 Jan 6;403(6765):41-5
references.pmid: 10638745
references.citation: Nat Chem Biol. 2010 Mar;6(3):238-243
references.pmid: 20139990
references.citation: Anal Biochem. 2003 Oct 15;321(2):202-8
references.pmid: 14511685
references.citation: J Neurochem. 2006 Jul;98(1):193-202
references.pmid: 16805808
references.citation: Mol Cell. 2003 Dec;12(6):1367-78
references.pmid: 14690592
references.citation: Drugs. 2009 Oct 1;69(14):1911-34
references.pmid: 19747008
references.citation: Nature. 1997 Sep 25;389(6649):349-52
references.pmid: 9311776
references.citation: Nat Rev Drug Discov. 2006 Sep;5(9):769-84
references.pmid: 16955068
references.citation: Mol Genet Metab. 2003 Sep-Oct;80(1-2):138-47
references.pmid: 14567963
references.citation: Biochem J. 2003 Mar 15;370(Pt 3):737-49
references.pmid: 12429021
references.citation: Anal Biochem. 1976 May 7;72:248-54
references.pmid: 942051
references.citation: J Am Chem Soc. 2004 Sep 8;126(35):10875-83
references.pmid: 15339172
references.citation: Anal Biochem. 1992 Aug 15;205(1):65-9
references.pmid: 1332537
references.citation: Annu Rev Biochem. 2001;70:81-120
references.pmid: 11395403
references.citation: Biochim Biophys Acta. 1969;185(2):269-86
references.pmid: 4980133
references.citation: Annu Rev Biochem. 2004;73:417-35
references.pmid: 15189148
references.citation: Structure. 2004 Jul;12(7):1325-34
references.pmid: 15242608
references.citation: Expert Rev Anticancer Ther. 2010 Jul;10(7):997-1008
references.pmid: 20645688
references.citation: FEBS Lett. 1995 Feb 27;360(2):111-4
references.pmid: 7875313
references.citation: Proc Natl Acad Sci U S A. 2004 Oct 19;101(42):15064-9
references.pmid: 15477595
references.citation: Expert Opin Investig Drugs. 2008 Feb;17(2):169-84
references.pmid: 18230051
references.citation: Proc Natl Acad Sci U S A. 1964 May;51:786-94
references.pmid: 14172992
references.citation: J Mol Biol. 2004 Apr 16;338(1):17-31
references.pmid: 15050820
references.citation: Chem Biol. 2003 Jan;10(1):61-8
references.pmid: 12573699
references.citation: J Biotechnol. 2006 Jun 25;124(1):258-70
references.pmid: 16567013
references.citation: Bioorg Med Chem Lett. 2009 Jul 1;19(13):3651-6
references.pmid: 19457659
references.citation: BMC Biotechnol. 2006 Mar 01;6:12
references.pmid: 16509985
references.citation: Biochemistry. 2004 Aug 31;43(34):11083-91
references.pmid: 15323567
references.citation: Curr Opin Struct Biol. 2005 Dec;15(6):673-80
references.pmid: 16263263
references.citation: Anal Biochem. 1996 Jun 1;237(2):260-73
references.pmid: 8660575
references.citation: Nat Rev Mol Cell Biol. 2001 Jun;2(6):422-32
references.pmid: 11389466
references.citation: Bioorg Med Chem Lett. 2008 May 1;18(9):2809-12
references.pmid: 18430569